Syneos Health
$76.819876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.
$76.81
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
+$3.70 (+5.06%) Today
$0.00 (0.00%) As of 1:00 AM UTC after-hours
Why Robinhood?
You can buy or sell Syneos Health and other stocks, options, and ETFs commission-free!
About SYNH
Syneos Health, Inc. provides outsourced clinical development and commercialization services to biopharmaceutical companies. It operates through the following business segments: Clinical Solutions and Commercial Solutions. The Clinical Solutions segment offers clinical development services spanning Phase I to Phase IV, including global studies, as well as unbundled service offerings such as clinical monitoring, investigator recruitment, patient recruitment, data management, and study startup to assist customers with their drug development process. The Commercial Solutions segment provides commercialization services, including outsourced field selling solutions, medication adherence, communications, and consulting services. The company was founded in 1998 and is headquartered in Morrisville, NC. The listed name for SYNH is Syneos Health, Inc. Class A Common Stock.
CEO
Alistair John Macdonald
Employees
24,310
Headquarters
Morrisville, North Carolina
Founded
1998
Market Cap
8.19B
Price-Earnings Ratio
40.49
Dividend Yield
—
Average Volume
667.47K
High Today
$76.81
Low Today
$72.51
Open Price
$73.99
Volume
993.77K
52 Week High
$81.35
52 Week Low
$30.02
SYNH News
Analyst Ratings
79%
of 14 ratings
Buy
79%
Hold
14%
Sell
7%
SYNH Earnings
$0.48
$0.69
$0.90
$1.11
Q2 FY19
Q3 FY19
Q4 FY19
Q1 FY20
Q2 FY20
Q3 FY20
Q4 FY20
Estimated
$1.10 per share
Actual
$1.11 per share